November 10, 2016 / 8:12 PM / in 10 months

BRIEF-BriaCell provides clinical development update on BriaVax

Nov 10 (Reuters) - Briacell Therapeutics Corp :

* BriaCell provides clinical development update on BriaVax(TM)

* To only use BriaVax newly generated by UC Davis Good Manufacturing Practice Facility in upcoming Phase I/IIA clinical trial

* Expects testing results for material intended to dose first patient in late December 2016, for clinical trial to initiate mid-late Q1 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below